Publications by authors named "Simone Bonardi"

Claim this Profile
W
When the diagnosis is written on the forehead.
Federico Pasin, Simone Bonardi, Antonio Modoni

Eur J Intern Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer.
Manuela Milani, Sergio Venturini, Simone Bonardi, Giovanni Allevi, Carla Strina

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Stephen B Fox, Daniele Generali, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi

Breast Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Teresa Mele, Daniele Generali, Stephen Fox, Maria Pia Brizzi, Alessandra Bersiga, Simone Bonardi

Breast Cancer Res Treat· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
Daniele Generali, Gaynor Bates, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi

Clin Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
Daniele Generali, Francesca M Buffa, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi

J Clin Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
Daniele Generali, Stephen B Fox, Maria Pia Brizzi, Giovanni Allevi, Simone Bonardi

Clin Cancer Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.
Daniele Generali, Alfredo Berruti, Marco Tampellini, Andrea Dovio, Sara Tedoldi, Simone Bonardi

Bone· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
Daniele Generali, Stephen B Fox, Alfredo Berruti, John W Moore, Maria Pia Brizzi, Simone Bonardi

Clin Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
Daniele Generali, Stephen B Fox, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi

Endocr Relat Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients.
Alberto Bottini, Daniele Generali, Maria Pia Brizzi, Stephen B Fox, Alessandra Bersiga, Simone Bonardi

J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
Daniele Generali, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi

Clin Cancer Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
Alfredo Berruti, Raffaella Bitossi, Alberto Bottini, Simone Bonardi, Michela Donadio

Eur J Cancer· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis